Who is sponsoring NCT04379310?

NCT04379310 is sponsored by Istanbul Nisantasi University.

What drugs are being tested in NCT04379310?

Interventions in NCT04379310: ACE Inhibitors and Calcium Channel Blockers.

Is NCT04379310 still recruiting?

NCT04379310 is currently completed. Last updated 5 June 2020.

Last reviewed 2020-06-05 · How we verify

NCT04379310: Covid-19

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019)

Completed Last updated 5 June 2020

What this trial tests

trial testing ACE Inhibitors and Calcium Channel Blockers in Covid-19 in 54 participants. Completed in 8 May 2020.

Timeline

1 May 2020

Primary endpoint
5 May 2020

8 May 2020

Quick facts

Lead sponsor	Istanbul Nisantasi University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	54
Start date	1 May 2020
Primary completion	5 May 2020
Estimated completion	8 May 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

ACE Inhibitors and Calcium Channel Blockers — full drug profile →

Conditions studied

Covid-19 — all drugs for Covid-19 →

Sponsor

Istanbul Nisantasi University

Who can join

Adults 18 to 99, any sex, with Covid-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators will recruit patients diagnosed with COVID-19 pneumonia between March 11th, 2020 and April 15th, 2020 in emergency, internal medicine and cardiology outpatient clinics, retrospectively and analyze their clinical and demographic features on admission in regard to their medications used for chronic diseases regularly.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.
Viana SD, Nunes S, Reis F. · · 2020 · cited 122× · PMID 32683039 · DOI 10.1016/j.arr.2020.101123
COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients.
Sieńko J, Kotowski M, Bogacz A, Lechowicz K, et al · · 2020 · cited 24× · PMID 32764907 · DOI 10.2147/cia.s261516
COVID-19 associated complications and potential therapeutic targets.
Monpara JD, Sodha SJ, Gupta PK. · · 2020 · cited 21× · PMID 32926918 · DOI 10.1016/j.ejphar.2020.173548
Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections.
Dubey AK, Chaudhry SK, Singh HB, Gupta VK, et al · · 2022 · cited 20× · PMID 35186674 · DOI 10.1016/j.btre.2022.e00712
COVID-19 pandemic: a glimpse into newly diagnosed hypertensive patients.
Yetkin E, Taylan G, Yalta K. · · 2021 · PMID 33629040 · DOI 10.1097/xce.0000000000000234

Verify or expand the search:

Other recruiting trials for Covid-19

Currently open trials in the same condition.

NCT05943743 — Hiccups and Obstacles Of E-Learning Among Medical Sudents · recruiting
NCT04466683 — Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia · Phase 2 · active not recruiting
NCT04433364 — COPE - COVID-19 in Pregnancy and Early Childhood · active not recruiting
NCT04568148 — COVID-19 Biorepository · active not recruiting
NCT04360538 — Long Term Outcomes of Patients With COVID-19 · active not recruiting

Other Istanbul Nisantasi University trials

Trials by the same sponsor.

NCT07428070 — Contextually Enriched Individualized Exercise Versus Contextually Fixed Exercise for Rotator Cuff-Related Shoulder Pain · NA · not yet recruiting
NCT07016204 — CBT Effects on Neurophysiological and Psychological Outcomes in Body Dysmorphic Disorder · NA · completed
NCT07037017 — CBT Effects on Neural, Physiological, and Attentional Responses in Anorexia Nervosa · NA · recruiting
NCT06844058 — Islamic-Oriented vs. Standard Ericksonian Hypnotherapy for Anxiety and Depression · NA · recruiting
NCT06758362 — EMDR vs. CBT for PTSD · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04379310 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Nisantasi University
Last refreshed: 5 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04379310.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing